null - FindTrial

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-003536-30-FR

Enrollment

4972

Registered

2012-08-14

Start date

2012-05-07

Completion date

Unknown

Last updated

2021-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: LLT Classification code 10048489 Term: Intrauterine growth retard System Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditions MedDRA version: 14.1 Level: LLT Classification code 10036492 Term: Pre-eclampsia toxemia System Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditions

Interventions

Trade Name: KARDEGIC Product Name: KARDEGIC Pharmaceutical Form: Powder for oral solution in sachet CAS Number: 62952-06-1 Other descriptive name: D,L-LYSINE ACETYLSALICYLATE Concentration unit: mg mi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 4972 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactAttaché de Recherche Clinique

CHRU de TOURS

yoann.desvignes@med.univ-tours.fr02.47.47.46.32

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026